Close

Kitov Pharma (KTOV) Signs License Agreement for KIT-302 in South Korea

March 8, 2017 9:05 AM EST Send to a Friend
Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV), an innovative biopharmaceutical company, announced today that the Company has signed a definitive License ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login